I've also been going to the restroom more regularly but not excessively
Mar 19, 2026, 12:04 ET Average weight loss of ~21% at 72 weeks in adults with obesity if all patients stayed on treatment * with Wegovy HD (~19% regardless of whether patients stayed on treatment ** ) in the STEP UP trial 1 In the STEP UP trial, about one in three trial participants taking Wegovy HD achieved 25% weight loss or higher 1 This approval for Wegovy further expands its already robust label inclusive of multiple formulations, including Wegovy pill, and indications not available with other GLP-1 weight loss medicines PLAINSBORO, N.J., March 19, 2026 /PRNewswire/ -- Novo Nordisk today announced US Food and Drug Administration (FDA) approval of a new higher dose of Wegovy , Wegovy HD (semaglutide) injection 7.2 mg, which demonstrated substantial weight loss in adults with obesity in the STEP UP trial
Dehydration Dehydration is another potential side effect of semaglutide that could impact your energy levels
What are the different types of green tea
Counterfeit GLP-1 Agonist Products A particularly alarming complication recently reported involves counterfeit GLP-1 agonist pens, especially fake Ozempic pens, which were found to contain insulin instead of semaglutide